Our Services
Pilot & Feasibility Program
Enrichment Program
Affiliate Investigators
Publications
Resources
News
- Events

Tesaglitazar, a dual peroxisome proliferator-activated receptor alpha/gamma agonist, reduces atherosclerosis in female low density lipoprotein receptor deficient mice

Tesaglitazar, a dual peroxisome proliferator-activated receptor alpha/gamma agonist, reduces atherosclerosis in female low density lipoprotein receptor deficient mice

News/Events

Call for Proposal: PILOT & FEASIBILITY 2025
April NORC Affiliate Investigator Spotlight: Carlos Campos, PhD
Calling all Mentors! CIMER (Center for the Improvement of Mentored Experiences in Research) Training on June 11, 2024
Clinical Research Unit Staff Announcements: Elaine Adams, RN & Robyn Fahlstrom, MPH, RN

Get Involved

Much of the good we accomplish is made possible by private support: by people and organizations underwriting leading-edge research and providing funding to train promising fellows. With your help, the UW Medicine Diabetes Institute is improving lives throughout the Northwest and around the world.

Learn More

Administrative Office: 206-616-2950 / Email: uwnorc@uw.edu

Copyright © 2024 | The University of Washington Nutrition and Obesity Research Center (UW NORC) is supported by grant P30 DK035816 from the National Institutes of Health’s National Institute of Diabetes and Digestive and Kidney Diseases. Please acknowledge the UW NORC grant number in all publications we supported.